Get the Stockscreener App
1.1096
0.04%
-0.0004
Therapeuticsmd Inc Stock (TXMD) Forecast
The Therapeuticsmd Inc (TXMD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $51.25, representing a +4,519% increase from the current price of $1.1096. The highest analyst price target is $51.05, and the lowest is $51.45.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TXMD Price Target
Average 38.04
(+3,328% Upside)
Is Therapeuticsmd Inc (TXMD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.96 | Neutral |
| STOCH(9,6) | 28.62 | Neutral |
| STOCHRSI(14) | 99.20 | Sell |
| MACD(12,26) | -0.00953 | Buy |
| ADX(14) | 22.77 | Neutral |
| William %R | -68.63 | Neutral |
| CCI(14) | 24.84 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0915
Buy
|
1.0987
Buy
|
| MA20 |
1.1073
Buy
|
1.1044
Buy
|
| MA50 |
1.1302
Sell
|
1.1269
Sell
|
| MA100 |
1.2047
Sell
|
1.1478
Sell
|
| MA200 |
1.1267
Sell
|
1.2447
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, TXMD could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on TXMD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.96 indicates that TXMD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.62 indicates that TXMD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 99.2 indicates that TXMD is oversold. This suggests that TXMD price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.77 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 24.84 indicates that TXMD is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TXMD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Therapeuticsmd Inc financial reports and earnings history, Therapeuticsmd Inc (TXMD) stock could reach $177.29 by 2030, $113.52 by 2040 and $372.23 by 2050. See the projected annual prices until 2050 of the Therapeuticsmd Inc stock below:
- Therapeuticsmd Inc (TXMD) is expected to reach an average price of $32.85 in 2035, with a high prediction of $38.22 and a low estimate of $33.66. This indicates an $2,861% rise from the last recorded price of $1.1096.
- Therapeuticsmd Inc (TXMD) stock is projected to chart a bullish course in 2040, with an average price target of $108.66, representing an $9,692% surge from its current level. The forecast ranges from a conservative $108.70 to a sky-high $113.52.
- Our analysts predict Therapeuticsmd Inc (TXMD) to jump 19,628% by 2045, soaring from $219.24 to an average price of $218.90, potentially reaching $223.09. While $219.24 is the low estimate, the potential upside is significant.
- Therapeuticsmd Inc (TXMD) stock is expected to climb by 2050, reaching an average of $355.53, a $31,941% jump from its current level. However, a wide range of estimates exists, with high and low targets of $372.23 and $363.12, respectively, highlighting the market's uncertainty.
Therapeuticsmd Inc Stock (TXMD) Year by Year Forecast
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2025
Therapeuticsmd Inc Stock (TXMD) is expected to reach an average price of $57.10 in 2025, with a high prediction of $89.06 and a low estimate of $25.15. This indicates an +5,046% rise from the last recorded price of $1.1096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $55.73 | $51.45 | $51.05 | +4,923% |
| November, 2025 | $44.94 | $52.94 | $55.17 | +3,950% |
| December, 2025 | $60.08 | $43.30 | $46.58 | +5,314% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2026
The predicted value for Therapeuticsmd Inc (TXMD) in 2026 is set at an average of $37.90. Estimates vary from a peak of $54.90 to a trough of $20.91, indicating an +3,316% surge from the present price of $1.1096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $50.28 | $55.78 | $53.36 | +4,432% |
| February, 2026 | $55.99 | $53.21 | $53.99 | +4,946% |
| March, 2026 | $45.20 | $49.20 | $54.42 | +3,973% |
| April, 2026 | $22.83 | $20.91 | $34.62 | +1,958% |
| May, 2026 | $32.04 | $35.04 | $29.19 | +2,788% |
| June, 2026 | $40.75 | $40.32 | $38.39 | +3,572% |
| July, 2026 | $51.38 | $50.03 | $48.41 | +4,531% |
| August, 2026 | $35.59 | $42.09 | $40.81 | +3,107% |
| September, 2026 | $42.72 | $40.87 | $40.85 | +3,750% |
| October, 2026 | $48.74 | $47.00 | $45.43 | +4,293% |
| November, 2026 | $54.39 | $53.30 | $52.64 | +4,802% |
| December, 2026 | $54.11 | $54.96 | $54.90 | +4,777% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Therapeuticsmd Inc (TXMD) is $228.32, with a high forecast of $404.36 and a low forecast of $52.27. This indicates an +20,477% increase from the last price of $1.1096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $50.52 | $52.98 | $52.70 | +4,453% |
| February, 2027 | $58.28 | $52.27 | $54.94 | +5,152% |
| March, 2027 | $62.83 | $57.99 | $62.83 | +5,562% |
| April, 2027 | $64.27 | $63.73 | $62.23 | +5,692% |
| May, 2027 | $65.73 | $65.46 | $64.31 | +5,824% |
| June, 2027 | $65.86 | $66.02 | $65.28 | +5,836% |
| July, 2027 | $55.08 | $55.40 | $54.95 | +4,864% |
| August, 2027 | $60.66 | $55.91 | $56.79 | +5,367% |
| September, 2027 | $66.78 | $61.71 | $404.36 | +5,918% |
| October, 2027 | $56.75 | $56.83 | $58.36 | +5,014% |
| November, 2027 | $54.86 | $54.97 | $56.01 | +4,844% |
| December, 2027 | $52.26 | $52.72 | $56.29 | +4,610% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2028
In 2028, Therapeuticsmd Inc (TXMD) is projected to reach an average price of $38.85, with a high projection of $49.85 and a low estimate of $27.84. This indicates an +3,401% rise from the last price of $1.1096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $49.00 | $49.78 | $49.85 | +4,316% |
| February, 2028 | $50.24 | $50.48 | $49.47 | +4,428% |
| March, 2028 | $47.69 | $48.16 | $49.32 | +4,198% |
| April, 2028 | $47.27 | $47.40 | $46.99 | +4,160% |
| May, 2028 | $43.24 | $43.11 | $46.24 | +3,797% |
| June, 2028 | $41.08 | $41.32 | $42.54 | +3,602% |
| July, 2028 | $39.28 | $39.37 | $40.45 | +3,440% |
| August, 2028 | $37.53 | $37.16 | $38.35 | +3,282% |
| September, 2028 | $35.56 | $35.62 | $36.53 | +3,105% |
| October, 2028 | $33.00 | $33.53 | $34.74 | +2,874% |
| November, 2028 | $29.56 | $29.94 | $31.66 | +2,564% |
| December, 2028 | $27.55 | $27.84 | $28.89 | +2,383% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2029
The 2029 price forecast for Therapeuticsmd Inc Stock (TXMD) is $53.66 on average, with a high prediction of $106.73 and a low estimate of $0.584. This represents an +4,736% increase from the previous price of $1.1096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $24.74 | $24.80 | $26.77 | +2,130% |
| February, 2029 | $22.48 | $22.84 | $23.88 | +1,926% |
| March, 2029 | $20.89 | $20.89 | $21.91 | +1,782% |
| April, 2029 | $19.38 | $19.57 | $20.17 | +1,647% |
| May, 2029 | $17.06 | $17.06 | $18.56 | +1,437% |
| June, 2029 | $14.03 | $14.17 | $16.07 | +1,164% |
| July, 2029 | $12.22 | $12.25 | $13.57 | +1,002% |
| August, 2029 | $9.3476 | $9.3476 | $11.54 | +742.43% |
| September, 2029 | $7.0651 | $7.0951 | $8.7045 | +536.72% |
| October, 2029 | $4.1594 | $4.2394 | $6.3341 | +274.86% |
| November, 2029 | $2.2969 | $2.2969 | $3.5363 | +107.00% |
| December, 2029 | $168.48 | $0.584 | $106.73 | +15,084% |
Therapeuticsmd Inc Stock (TXMD) Price Forecast for 2030
Therapeuticsmd Inc Stock (TXMD) is expected to reach an average price of $180.85 in 2030, with a high forecast of $229.62 and a low forecast of $132.07. This signifies an +16,199% surge from the last price of $1.1096.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $213.00 | $179.58 | $177.29 | +19,096% |
| February, 2030 | $204.91 | $206.41 | $196.46 | +18,367% |
| March, 2030 | $223.92 | $219.02 | $215.33 | +20,080% |
| April, 2030 | $178.74 | $190.99 | $176.74 | +16,009% |
| May, 2030 | $133.26 | $136.51 | $174.35 | +11,910% |
| June, 2030 | $170.42 | $132.07 | $128.87 | +15,259% |
| July, 2030 | $167.20 | $176.34 | $166.70 | +14,968% |
| August, 2030 | $186.36 | $182.05 | $174.90 | +16,695% |
| September, 2030 | $179.78 | $181.17 | $177.53 | +16,102% |
| October, 2030 | $166.04 | $170.29 | $162.19 | +14,864% |
| November, 2030 | $214.96 | $190.65 | $201.40 | +19,273% |
| December, 2030 | $236.09 | $232.40 | $229.62 | +21,177% |
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):